What is the appropriate management for a pediatric patient with herpangina presenting with fever?

Management of Herpangina with Fever in Pediatric Patients

Herpangina is a self-limited viral illness requiring only supportive care, with fever management and adequate hydration being the cornerstones of treatment. 1, 2

Clinical Overview

Herpangina is an acute infectious disease caused by enteroviruses, most commonly Coxsackievirus-A, Enterovirus-A, and Echovirus. 2 The condition presents with fever, irritability, and characteristic painful vesicles and ulcers in the posterior pharynx, soft palate, and tonsillar pillars. 1, 2

Diagnostic Approach

• Clinical diagnosis is based on the typical appearance of vesicles and ulcers in the posterior oropharynx, combined with fever and history of epidemiological exposure. 2
• Virological confirmation via PCR can be obtained but is not necessary for routine management. 1, 2
• The disease typically affects children and has a characteristic 4-6 day course with good prognosis. 2

Treatment Protocol

Symptomatic Management (Primary Approach)

Fever and Pain Control:

• Antipyretics and analgesics should be administered to keep the child comfortable and maintain adequate oral intake. 3
• Topical oral spray with benzydamine (0.255 mg/dose, 6 doses 3 times daily) can provide local pain relief. 1

Hydration and Nutrition:

• Adequate rehydration is essential, as painful oral lesions may reduce fluid intake. 1
• Diet modification: exclude salty, spicy, and fried foods that may irritate oral lesions. 1
• Children unable to maintain fluid intake due to pain or vomiting may require intravenous fluids at 80% basal levels with electrolyte monitoring. 3

Activity Restrictions:

• Restrict physical activity during the acute phase. 1
• Exclude thermal procedures (hot baths, saunas). 1

Antiviral Considerations

• Topical antiviral oral sprays may be incorporated into symptomatic treatment. 2
• Inosine pranobex (50 mg/kg/day divided into doses, typically 500 mg tablets based on weight) for 7 days has been used in clinical practice, though evidence is limited. 1
• Systemic antivirals are not routinely indicated for uncomplicated herpangina, as the disease is self-limited. 2

Monitoring and Follow-Up

• Most children show complete regression of symptoms by day 10 from disease onset. 1
• Monitor for adequate hydration status, particularly in younger children. 3
• Watch for complications such as dehydration or secondary bacterial infections, though these are uncommon. 2

Important Caveats

Do not confuse with HSV gingivostomatitis: While both present with oral lesions and fever, HSV typically causes anterior mouth involvement (gingiva, lips, tongue) with more severe and prolonged symptoms, whereas herpangina affects the posterior pharynx. 3

Antibiotics are not indicated unless there is clear evidence of secondary bacterial infection, which is rare in herpangina. 2

Hospital admission criteria would include:

• Inability to maintain hydration (decreased urine output, signs of dehydration). 3
• Respiratory compromise (though uncommon with herpangina alone). 3
• Severe pain preventing any oral intake. 3